Agreed on all counts and to be honest I have no idea why you would sell at this level. I get that the macro environment not so good and the volume has significantly dropped off, so not too worried. That said, I am now actually thinking Tomie approval will not move the share price to much, but gee I will be happy to be proved wrong.
Investor confidence has been absolutely destroyed since our good old friend started selling by having "all shareholders interest in their mind". Why would anyone keep buying the bids when there is a massive black cloud hanging over the company's largest holder. All IMO of course and I am wrong most of the time.
Being an investor in ALK is very frustrating. Management just need to start selling the story better and get some big inventors excited about the future. Cause by the looks there are not many at present.
Keenly awaiting any positive news!
- Forums
- ASX - By Stock
- ALK
- Ann: Investor Presentation - Bell Potter Unearthed
Ann: Investor Presentation - Bell Potter Unearthed, page-62
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.5¢ |
Change
-0.005(0.91%) |
Mkt cap ! $328.9M |
Open | High | Low | Value | Volume |
55.0¢ | 56.0¢ | 54.0¢ | $681.4K | 1.244M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 99104 | 54.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 108578 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 101540 | 0.545 |
9 | 77578 | 0.540 |
6 | 97590 | 0.535 |
12 | 180499 | 0.530 |
4 | 16034 | 0.525 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 111120 | 15 |
0.560 | 40999 | 4 |
0.565 | 24028 | 3 |
0.570 | 54100 | 5 |
0.575 | 77000 | 2 |
Last trade - 15.30pm 15/07/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online